CB1R

Feng Wang1, Zehui Liu2, Jingyi Hu1

  • 1Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin, China; Heilongjiang Province Key Laboratory of Child Development and Genetic Research, Harbin Medical University, China; Key Laboratory of Precision Nutrition and Health, Ministry of Education, Harbin Medical University, Heilongjiang, China.

Life sciences
|June 8, 2025
PubMed
概括

向大麻素1型受体 (CB1R) 显示出治疗自闭症谱系障碍 (ASD) 的前景. 激活CB1R在小鼠模型中改善了突触功能和类似ASD的行为,这表明了新的治疗策略.